Not applicableStudy completedNCT05572450What this trial is testingDose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainWho this might be right forInfluenza A H1N1 Hvivo 70
Early research (Phase 1)Study completedNCT00724997What this trial is testingRandomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy VolunteersWho this might be right forSeasonal Human Influenza AVIR Green Hills Biotechnology AG 48
Very early researchStudy completedNCT03277456What this trial is testingDetermine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1Who this might be right forHuman Volunteers Barinthus Biotherapeutics 6
Testing effectiveness (Phase 2)Study completedNCT02423577What this trial is testingSafety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge StrainWho this might be right forInfluenza Autoimmune Technologies, LLC 79
Early research (Phase 1)Study completedNCT01806909What this trial is testingIntranasal AD4-H5-VTN as an Adenovirus VaccineWho this might be right forHealthy Volunteer National Institute of Allergy and Infectious Diseases (NIAID) 51
Early research (Phase 1)Study completedNCT01258530What this trial is testingEvaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy VolunteersWho this might be right forInfluenza, Human GlaxoSmithKline 28
Early research (Phase 1)UnknownNCT06046092What this trial is testingH7HLAII DNA Influenza VaccineWho this might be right forInfluenza APandemic Influenza Oslo University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00952419What this trial is testingDifferent Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 YearsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 474
Large-scale testing (Phase 3)Study completedNCT00970177What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 812
Not applicableEnded earlyNCT01315418What this trial is testingEffect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor SituationWho this might be right forUpper Respiratory Tract InfectionsRhinopharyngitisSore Throat+8 more Danone Global Research & Innovation Center 239
Early research (Phase 1)Looking for participantsNCT07516418What this trial is testingStudy of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of AgeWho this might be right forRespiratory Syncytial Virus (RSV)Influenza A(H5N1) Sanofi 570
Testing effectiveness (Phase 2)Study completedNCT04025580What this trial is testingSystems Analyses of the Immune Response to the Seasonal Influenza VaccineWho this might be right forHealthy Volunteer National Institute of Allergy and Infectious Diseases (NIAID) 98
Testing effectiveness (Phase 2)Study completedNCT02649192What this trial is testingInfluenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in ChildrenWho this might be right forHealthy Participants St. Jude Children's Research Hospital 87
Early research (Phase 1)Study completedNCT05202379What this trial is testingCC-42344 Safety Study in Healthy ParticipantsWho this might be right forInfluenza A Cocrystal Pharma, Inc. 80
Early research (Phase 1)UnknownNCT02188810What this trial is testingSafety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy AdultsWho this might be right forFlu Folia Biotech Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02853617What this trial is testingAV0328 Administered to Healthy Adult VolunteersWho this might be right forPNAG-expressing Pathogenic Microbes Vaccine Alopexx Vaccine, LLC 16
Large-scale testing (Phase 3)Study completedNCT02612909What this trial is testingA Safety and Immunogenicity Study of IVACFLU-A/H5N1Who this might be right forAvian Influenza Institute of Vaccines and Medical Biologicals, Vietnam 930
Early research (Phase 1)Study completedNCT01406418What this trial is testingAssessment of CR6261, a Monoclonal Antibody Against the Influenza A VirusWho this might be right forInfluenza Crucell Holland BV 64
Testing effectiveness (Phase 2)Study completedNCT04034290What this trial is testingRandomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVacWho this might be right forHealthy Volunteers Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 224
Early research (Phase 1)Looking for participantsNCT07305207What this trial is testingEstablishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic PreparednessWho this might be right forInfluenza (Healthy Volunteers) Dalhousie University 32